Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 46 AL 60

[Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]

Asai M, Shirotani K, Kondo T, Inoue H, Iwata N.

Nihon Yakurigaku Zasshi. 2014 Jan;143(1):23-6. doi: 10.1254/fpj.143.23.

Effect of TTP488 in patients with mild to moderate Alzheimer's disease

Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM.

BMC Neurol. 2014 Jan 15;14:12. doi: 10.1186/1471-2377-14-12.

Therapeutic implications of the prostaglandin pathway in Alzheimer's disease

Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD.

Biochem Pharmacol. 2014 Apr 15;88(4):565-72. doi: 10.1016/j.bcp.2013.12.014. Epub 2014 Jan 13.

The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area

Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J.

Int J Geriatr Psychiatry. 2014 Sep;29(9):881-9. doi: 10.1002/gps.4074. Epub 2014 Jan 17.

Antiamyloid therapy for Alzheimer's disease--are we on the right road?

Karran E, Hardy J.

N Engl J Med. 2014 Jan 23;370(4):377-8. doi: 10.1056/NEJMe1313943.

A brief report on the efficacy of donepezil in pain management in Alzheimer's disease

Gharaei H, Shadlou H.

J Pain Palliat Care Pharmacother. 2014 Mar;28(1):37-9. doi: 10.3109/15360288.2013.876484. Epub 2014 Jan 23.

Galantamine treatment in outpatients with mild Alzheimer's disease

Richarz U, Gaudig M, Rettig K, Schauble B.

Acta Neurol Scand. 2014 Jun;129(6):382-92. doi: 10.1111/ane.12195. Epub 2014 Jan 25.

Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines

Puzzo D, Lee L, Palmeri A, Calabrese G, Arancio O.

Biochem Pharmacol. 2014 Apr 15;88(4):450-67. doi: 10.1016/j.bcp.2014.01.011. Epub 2014 Jan 21.

New perspectives on the role of tau in Alzheimer's disease. Implications for therapy

Medina M, Avila J.

Biochem Pharmacol. 2014 Apr 15;88(4):540-7. doi: 10.1016/j.bcp.2014.01.013. Epub 2014 Jan 22.

From the editor

Garner JD.

J Women Aging. 2014;26(1):1-2. doi: 10.1080/08952841.2013.815562.

Phytoestrogens and cognitive function: a review

Soni M, Rahardjo TB, Soekardi R, Sulistyowati Y, Lestariningsih, Yesufu-Udechuku A, Irsan A, Hogervorst E.

Maturitas. 2014 Mar;77(3):209-20. doi: 10.1016/j.maturitas.2013.12.010. Epub 2014 Jan 8.

Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?

Fischer A.

Neuropharmacology. 2014 May;80:95-102. doi: 10.1016/j.neuropharm.2014.01.038. Epub 2014 Jan 31.

Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study

Chang YS, Chen HL, Hsu CY, Tang SH, Liu CK.

J Clin Neurophysiol. 2014 Feb;31(1):81-5. doi: 10.1097/01.wnp.0000436899.48243.5e.

Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces

Rosini M, Simoni E, Minarini A, Melchiorre C.

Neurochem Res. 2014 Oct;39(10):1914-23. doi: 10.1007/s11064-014-1250-1. Epub 2014 Feb 4.

Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease

Drolle E, Hane F, Lee B, Leonenko Z.

Drug Metab Rev. 2014 May;46(2):207-23. doi: 10.3109/03602532.2014.882354. Epub 2014 Feb 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias